Jefferies

Metagenomi Announces Closing of Initial Public Offering

Retrieved on: 
Tuesday, February 13, 2024

EMERYVILLE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced the closing of its previously announced initial public offering of 6,250,000 of its common stock at a price to the public of $15.00 per share.

Key Points: 
  • EMERYVILLE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced the closing of its previously announced initial public offering of 6,250,000 of its common stock at a price to the public of $15.00 per share.
  • The aggregate gross proceeds to Metagenomi from the offering were approximately $93.75 million, before deducting underwriting discounts and commissions and offering expenses.
  • In addition, Metagenomi has granted the underwriters a 30-day option to purchase up to an additional 937,500 of its common stock at the initial public offering price less underwriting discounts and commissions.
  • J.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities and BMO Capital Markets acted as book-running managers for the offering.

Oportun Completes $200 Million Asset Backed Securitization

Retrieved on: 
Tuesday, February 13, 2024

SAN CARLOS, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech, today announced the issuance of $200 million of fixed rate asset-backed notes secured by a pool of unsecured and secured installment loans.

Key Points: 
  • SAN CARLOS, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech, today announced the issuance of $200 million of fixed rate asset-backed notes secured by a pool of unsecured and secured installment loans.
  • The offering included four classes of fixed rate notes: Class A, Class B, Class C, and Class D. KBRA rated all classes of notes, assigning ratings of AA-, A-, BBB-, and BB-, respectively.
  • All classes of notes were placed with four institutions as the initial purchasers: Morgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Jefferies.
  • “The significant demand for and pricing of this securitization reflects investor confidence in the credit quality of Oportun’s consumer loans and our business model,” said Jonathan Coblentz, Chief Financial Officer at Oportun.

Whole Earth Brands Signs Definitive Agreement to be Acquired by Affiliates of Sababa Holdings FREE, LLC

Retrieved on: 
Tuesday, February 13, 2024

CHICAGO and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Whole Earth Brands, Inc. (the “Company” or “we” or “our”) (Nasdaq: FREE), a global food company enabling healthier lifestyles through premium plant-based sweeteners, flavor enhancers and other foods, today confirmed that the Company entered into a definitive agreement pursuant to which Ozark Holdings, LLC (which, going forward, intends to do business as Sweet Oak Parent) (“Sweet Oak”), an affiliate of Sababa Holdings FREE, LLC (“Sababa”), will acquire all of the outstanding shares of the Company’s common stock that it does not already own in an all-cash transaction for $4.875 per share (the “Transaction”). This represents a 56% premium over the Company’s share price at market close on June 23, 2023 prior to receiving Sababa’s initial $4.00 per share bid and a 37% premium over the Company’s 60-day volume-weighted average price (“VWAP”) as of February 12, 2024.

Key Points: 
  • The Company expects to release its customary financial results for the fourth quarter and full year ended December 31, 2023 in March 2024.
  • Upon completion of the Transaction, the Company’s common stock will no longer be listed on the NASDAQ Stock Market.
  • Silver Point Finance LLC and Fortress Credit Corp. and its affiliates are providing debt financing in connection with the Transaction.
  • Citi is serving as M&A advisor and capital markets advisor to Sweet Oak, and Greenberg Traurig, P.A.

Transom Capital Group Enters EV Market with Acquisition of Webasto Charging Solutions

Retrieved on: 
Monday, February 12, 2024

LOS ANGELES, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Transom Capital Group (“Transom”), an operations-focused middle market private equity firm, is acquiring Webasto Charging Solutions, Inc. from Webasto Group, a top 100 supplier to the automotive industry worldwide.

Key Points: 
  • LOS ANGELES, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Transom Capital Group (“Transom”), an operations-focused middle market private equity firm, is acquiring Webasto Charging Solutions, Inc. from Webasto Group, a top 100 supplier to the automotive industry worldwide.
  • Webasto Charging Solutions is a leading provider of electric vehicle charging products and services.
  • Transom is acquiring a major stake in the business and Webasto will remain a minority shareholder.
  • “Charging is at the forefront of the global transition toward electric vehicles, and Webasto presented a rare opportunity to invest in a business of significant scale and in an underlying market on a hockey stick growth curve,” said Russ Roenick, co-founder and managing partner at Transom Capital Group.

Scheme Effective

Retrieved on: 
Monday, February 12, 2024

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.
  • This announcement is not an offer of securities for sale into the United States.
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Suspension of Trading in Shares

Retrieved on: 
Monday, February 12, 2024

The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.

Key Points: 
  • The Consideration Shares will be offered and sold for investment purposes only in the United States or to U.S.
  • Consideration Shares will be offered and sold outside of the United States to investors that are not U.S.
  • The transferability of the Consideration Shares will be further restricted by the terms of the AI/QP Investor Letter, and any re-offer or resale of any Consideration Shares in the United States or to U.S.
  • RTW Bio reserves the right to refuse to accept any subscriptions, resales or other transfers of Consideration Shares to U.S.

Owens Corning Announces $3.9 Billion Acquisition of Masonite to Strengthen Position in Building and Construction Materials

Retrieved on: 
Friday, February 9, 2024

Founded in 1925, Masonite designs, manufactures, and markets doors and door systems, with a vertically integrated manufacturing model serving both repair and remodel and new construction demand.

Key Points: 
  • Founded in 1925, Masonite designs, manufactures, and markets doors and door systems, with a vertically integrated manufacturing model serving both repair and remodel and new construction demand.
  • Masonite operates 64 manufacturing and distribution facilities, primarily in North America, and has over 10,000 employees globally.
  • With the acquisition, Owens Corning’s revenue generated from North American residential applications will grow to 60% of its total revenue.
  • The acquisition also increases Owens Corning’s total addressable market by $27 billion and creates a platform to drive new growth opportunities in other product adjacencies.

Metagenomi Announces Pricing of Initial Public Offering

Retrieved on: 
Friday, February 9, 2024

EMERYVILLE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (“Metagenomi”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a price to the public of $15.00 per share.

Key Points: 
  • EMERYVILLE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (“Metagenomi”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a price to the public of $15.00 per share.
  • The gross proceeds to Metagenomi from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $93,750,000.
  • All of the shares are being offered by Metagenomi.
  • In addition, Metagenomi has granted the underwriters a 30-day option to buy an additional 937,500 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

Oppenheimer Further Expands Public Finance Banking Team with Appointments of Kristin Stephens and David Moffett

Retrieved on: 
Thursday, February 8, 2024

NEW YORK, Feb. 8, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading financial services firm and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kristin Stephens and David Moffett have joined the Public Finance team as Managing Directors. Ms. Stephens will be based in New York and serve as Head of the Northeast Region while Mr. Moffett will work out of Atlanta and be Head of the Southeast Region. Each will report to Elizabeth (Beth) Coolidge, the newly appointed Head of Public Finance.

Key Points: 
  • Each will report to Elizabeth (Beth) Coolidge, the newly appointed Head of Public Finance.
  • "We are thrilled to have Kristin and David join our team," said Coolidge, who leads the Public Finance team from Chicago.
  • These appointments bolster Oppenheimer's Public Finance team, which includes approximately 25 professionals.
  • I am excited to join such a forward-thinking team and to help enhance Oppenheimer's Public Finance capabilities in the Southeast Region."

Pagaya Closes Five-Year $280M Credit Facility with BlackRock, UBS, JPMorgan Chase and Other Lenders

Retrieved on: 
Wednesday, February 7, 2024

Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya" or “the Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, announced today the closing of a credit facility with participation from Funds and Accounts managed by BlackRock U.S.

Key Points: 
  • Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya" or “the Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, announced today the closing of a credit facility with participation from Funds and Accounts managed by BlackRock U.S.
  • Private Capital (“BlackRock”), UBS O’Connor, JPMorgan Chase, Valley Bank, and Israel Discount Bank.
  • “We are pleased to partner with Pagaya and support its next stage of growth through this facility,” said Dan Worrell, Managing Director at BlackRock.
  • Proceeds from the facility will be used to pay off outstanding borrowings from the Company's previous facility, invest in product innovation, and grow its network with both existing and new lending and investor partners.